Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression
Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression
Serezani, C.H., et al. 2011. J. Clin. Invest. 121: 671-682
Speaker: Yu-Ting Liao (廖郁婷) Time: 14:10~15:00, Mar. 9, 2011
Commentator: Dr. Chi-Chang Shieh (謝奇璋老師) Place: Room 601
Abstract:
Leukotriene B4 (LTB4) serves as a mediator in 5-lipoxygenase-mediated (5-LO-mediated) biosynthesis and has been implied its function of antimicrobial defense. Several studies suggested that 5-LO metabolites involved in LPS-induced response. However, the role of LTB4 in regulating TLR signaling and cytokine responses is still unknown. First, the authors found that production of NF-κB-dependent cytokines enhanced by MyD88-dependent agonists depend on 5-LO metabolites in vitro and in vivo. The DNA binding activity and LPS-induced translocation of NF-κB were attenuated in 5-LO-/- and BLT1-/- macrophages. Exogeous LTB4 restored MyD88 expression in 5-LO-/- ,but not in BLT1-/- macrophages. The activation of MyD88 transcription factor STAT1 increased by LTB4 which depended on JAK2 phosphorylation and Gαi signaling. Moreover, LTB4/BLT1/Gαisignaling restrained SOCS1 by enhancing its mRNA degradation. By using siRNA to knockdown SOCS1, MyD88expression and LPS-induced secretion of proinflammatory molecules were recovered. Collectively, the results showed that LTB4/BLT1/Gαi axis reduced SOCS1 to inhibit JAK2/STAT1-mediated MyD88expression and further influence the production of NF-κB-dependent cytokines in TLR-induced responses.
References: